NorthRock Partners’s CME Group CME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-100
Closed -$27.6K 878
2025
Q2
$27.6K Buy
+100
New +$27.2K ﹤0.01% 677

Other funds holding CME

NorthRock Partners's CME Position: Q1 2026 in Review

NorthRock Partners reduced its CME Group (CME) stake by 26% in Q1 2026, selling an estimated $127K and leaving 1,214 shares worth $359K. The position accounts for 0.01% of the portfolio, ranked #480.

NorthRock Partners first reported a position in CME in Q3 2019 and has held it in 16 quarters since. The position peaked at $1.12M in Q2 2025. 1,791 funds tracked by Wall St. Rank hold CME as of Q1 2026.

  • NorthRock Partners held 1,214 shares of CME Group worth $359K as of Q1 2026.
  • NorthRock Partners sold 429 CME Group shares in Q1 2026, an estimated $127K.
  • CME Group made up 0.01% of NorthRock Partners's portfolio in Q1 2026, its #480 holding.
  • NorthRock Partners first reported a position in CME Group in Q3 2019 and has held it in 16 quarters since.
  • NorthRock Partners's CME Group position peaked at $1.12M in Q2 2025.
  • 1,791 funds tracked by Wall St. Rank held CME Group as of Q1 2026.

Based on NorthRock Partners's 13F filing for Q1 2026, filed 15 May 2026.